Laura A Andrews, MD | |
1550 Midway Pl, Menasha, WI 54952-1165 | |
(920) 727-8030 | |
Not Available |
Full Name | Laura A Andrews |
---|---|
Gender | Female |
Speciality | Endocrinology |
Experience | 25 Years |
Location | 1550 Midway Pl, Menasha, Wisconsin |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548254535 | NPI | - | NPPES |
34614100 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 47650 (Wisconsin) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ascension Ne Wisconsin - St Elizabeth Campus | Appleton, WI | Hospital |
Thedacare Regional Med Ctr - Neenah | Neenah, WI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ascension Medical Group-fox Valley Wisconsin Inc | 0244142420 | 258 |
News Archive
Novelos Therapeutics, Inc., a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that primary and secondary endpoints were not met in Novelos' pivotal Phase 3 trial in advanced non-small cell lung cancer (NSCLC) with its lead product, NOV-002, in combination with first-line chemotherapy.
Injury kills more 11-year-olds in the United States than all other causes combined, and a new study from University of Alabama at Birmingham reveals ADHD almost doubles the risk of serious injury among this age group.
A team of scientists led by Research Associate Professor Motomi Osato and Professor Yoshiaki Ito from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) found that a drug originally designed for killing a limited type of cancer cells with DNA repair defects could potentially be used to treat leukaemia and other cancers.
Outside of Asia, Denmark became the first nation to ease the forced social distancing norms or lockdown. Last week on Thursday, the officials declared that since the removal of the lockdown, there had been no rise in the number of COVID-19 cases. Their easing of the lockdown rules has been gradual, say the officials, and this process began in mid-April. There have been 9,721 reported cases and 484 deaths due to COVID-19 to date. The number of cases has also declined since 7th April.
› Verified 6 days ago
Entity Name | Ascension Medical Group-fox Valley Wisconsin Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1730126392 PECOS PAC ID: 0244142420 Enrollment ID: O20031105000351 |
News Archive
Novelos Therapeutics, Inc., a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that primary and secondary endpoints were not met in Novelos' pivotal Phase 3 trial in advanced non-small cell lung cancer (NSCLC) with its lead product, NOV-002, in combination with first-line chemotherapy.
Injury kills more 11-year-olds in the United States than all other causes combined, and a new study from University of Alabama at Birmingham reveals ADHD almost doubles the risk of serious injury among this age group.
A team of scientists led by Research Associate Professor Motomi Osato and Professor Yoshiaki Ito from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) found that a drug originally designed for killing a limited type of cancer cells with DNA repair defects could potentially be used to treat leukaemia and other cancers.
Outside of Asia, Denmark became the first nation to ease the forced social distancing norms or lockdown. Last week on Thursday, the officials declared that since the removal of the lockdown, there had been no rise in the number of COVID-19 cases. Their easing of the lockdown rules has been gradual, say the officials, and this process began in mid-April. There have been 9,721 reported cases and 484 deaths due to COVID-19 to date. The number of cases has also declined since 7th April.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Laura A Andrews, MD 1550 Midway Pl, Menasha, WI 54952-1165 Ph: (920) 727-8030 | Laura A Andrews, MD 1550 Midway Pl, Menasha, WI 54952-1165 Ph: (920) 727-8030 |
News Archive
Novelos Therapeutics, Inc., a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that primary and secondary endpoints were not met in Novelos' pivotal Phase 3 trial in advanced non-small cell lung cancer (NSCLC) with its lead product, NOV-002, in combination with first-line chemotherapy.
Injury kills more 11-year-olds in the United States than all other causes combined, and a new study from University of Alabama at Birmingham reveals ADHD almost doubles the risk of serious injury among this age group.
A team of scientists led by Research Associate Professor Motomi Osato and Professor Yoshiaki Ito from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) found that a drug originally designed for killing a limited type of cancer cells with DNA repair defects could potentially be used to treat leukaemia and other cancers.
Outside of Asia, Denmark became the first nation to ease the forced social distancing norms or lockdown. Last week on Thursday, the officials declared that since the removal of the lockdown, there had been no rise in the number of COVID-19 cases. Their easing of the lockdown rules has been gradual, say the officials, and this process began in mid-April. There have been 9,721 reported cases and 484 deaths due to COVID-19 to date. The number of cases has also declined since 7th April.
› Verified 6 days ago
Kent L Partain, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1550 Midway Pl, Menasha, WI 54952 Phone: 920-727-8020 | |
Edward S Scanlan, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1550 Midway Pl, Menasha, WI 54952 Phone: 920-727-5633 | |
Ghada Metwally Ahmed Elsayed, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1550 Midway Pl, Menasha, WI 54952 Phone: 920-727-8020 | |
Elzbieta Perry, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1550 Midway Pl, Menasha, WI 54952 Phone: 608-333-6018 | |
Ann M Gierl, DO Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1550 Midway Pl, Menasha, WI 54952 Phone: 920-727-8020 | |
Eric C Gowing, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1550 Midway Pl, Menasha, WI 54952 Phone: 920-727-8020 |